Today, Dec. 29, 2025, UiPath continues its upward trajectory as Morgan Stanley analysts up their price target.

UiPath's (NYSE: PATH) first-quarter report was a baffling affair. The reported results were within management's guidance ranges, but a top-end revenue reading was undermined by low-range profits and ...

Wondering if UiPath is still a smart way to play the AI and automation theme, or if the easy money has already been made? Here is a look at the numbers so you can decide if the current price really ...

UiPath faces significant challenges, and its stock price reflects them. Leadership changes and solid financial metrics could pave the way to a recovery. The stock price is down 54% from recent highs, ...

UiPath (NYSE:PATH – Free Report) had its price target reduced by BMO Capital Markets from $16.00 to $11.50 in a report published on Friday morning,Benzinga reports. They currently have a market ...

BMO Capital raised the firm’s price target on UiPath (PATH) to $16 from $15 and keeps a Market Perform rating on the shares. The company had a reasonable quarter, with modest upside in key metrics ...

Canaccord Genuity: UiPath reported revenues of $411 million and non-GAAP operating income of $88 million, beating guidance by $19 million and $18 million, respectively, Crane said in a note. ARR ...

UiPath is a buy due to its strong recurring revenue, high gross margins, and horizontal product relevance across industries, despite recent sales slowdowns. The company has implemented strategic ...

UiPath offers an AI-driven automation platform, targeting workflow efficiency and accessibility for a broad range of users. PATH is undervalued, trading at a forward P/E of 22, an 11% discount to the ...

UiPath, Inc. (NYSE:PATH) shares are trading higher after the company reported better-than-expected first-quarter results, issued second-quarter sales guidance above estimates, and raised its FY26 ...